As of February 2022, SARS-CoV-2 is still one of the most
serious public health threats due to its high mortality rate and
rapid spread of novel variants. Since the first outbreak in 2019,
general understanding of SARS-CoV-2 has been improved
through basic and clinical studies; however, knowledge gaps
still exist in our understanding of the emerging novel SARSCoV-
2 variants, which impacts the corresponding development
of vaccines and therapeutics. Especially, accumulation of
mutations in SARS-CoV-2 and rapid spread in populations
with previous immunity has resulted in selection of variants
that evade the host immune response. This phenomenon threatens
to render current SARS-CoV-2 vaccines ineffective for
controlling the pandemic. Proper animal models are essential
for detailed investigations into the viral etiology, transmission
and pathogenesis mechanisms, as well as evaluation of the
efficacy of vaccine candidates against recent SARS-CoV-2
variants. Further, the choice of animal model for each research
topic is important for researchers to gain better knowledge
of recent SARS-CoV-2 variants. Here, we review the advantages
and limitations of each animal model, including mice,
hamsters, ferrets, and non-human primates, to elucidate variant
SARS-CoV-2 etiology and transmission and to evaluate
therapeutic and vaccine efficacy.
Citations
Citations to this article as recorded by
In vivo characterization of ACE2 expression in Sprague-Dawley rats and cultured primary brain pericytes highlights the utility of Rattus norvegicus in the study of COVID-19 brain pathophysiology Eugene Park, Elaine Liu, Andrew J. Baker Brain Research.2025; 1848: 149333. CrossRef
Utilizing non‐human primate models to combat recent COVID‐19/SARS‐CoV‐2 and viral infectious disease outbreaks Taeho Kwon Journal of Medical Primatology.2024;[Epub] CrossRef
Early detection of highly transmissible viral variants using phylogenomics Michael R. May, Bruce Rannala Science Advances.2024;[Epub] CrossRef
Animal Models, Zoonotic Reservoirs, and Cross-Species Transmission of Emerging Human-Infecting Coronaviruses Yakhouba Kane, Gary Wong, George F. Gao Annual Review of Animal Biosciences.2023; 11(1): 1. CrossRef
SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets Elizabeth E. Zumbrun, Samantha E. Zak, Eric D. Lee, Philip A. Bowling, Sara I. Ruiz, Xiankun Zeng, Jeffrey W. Koehler, Korey L. Delp, Russel R. Bakken, Shannon S. Hentschel, Holly A. Bloomfield, Keersten M. Ricks, Tamara L. Clements, April M. Babka, John Viruses.2023; 15(12): 2341. CrossRef
The Isolation and In Vitro Differentiation of Primary Fetal Baboon Tracheal Epithelial Cells for the Study of SARS-CoV-2 Host-Virus Interactions Bharathiraja Subramaniyan, Sunam Gurung, Manish Bodas, Andrew R. Moore, Jason L. Larabee, Darlene Reuter, Constantin Georgescu, Jonathan D. Wren, Dean A. Myers, James F. Papin, Matthew S. Walters Viruses.2023; 15(4): 862. CrossRef
Distinctive Combinations of RBD Mutations Contribute to Antibody Evasion in the Case of the SARS-CoV-2 Beta Variant Tae-Hun Kim, Sojung Bae, Sunggeun Goo, Jinjong Myoung Journal of Microbiology and Biotechnology.2023; 33(12): 1587. CrossRef
Two years of COVID-19 pandemic: where are we now? Jinjong Myoung Journal of Microbiology.2022; 60(3): 235. CrossRef
SARS CoV-2 (Delta Variant) Infection Kinetics and Immunopathogenesis in Domestic Cats Miruthula Tamil Selvan, Sachithra Gunasekara, Ping Xiao, Kristen Griffin, Shannon R. Cowan, Sai Narayanan, Akhilesh Ramachandran, Darren E. Hagen, Jerry W. Ritchey, Jennifer M. Rudd, Craig A. Miller Viruses.2022; 14(6): 1207. CrossRef